COCP
Cocrystal Pharma
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
News
- Cocrystal Pharma received FDA Fast Track designation for CDI-988 for treatment and prevention of norovirusApr 2, 2026
- Cocrystal Pharma dosed the first participants in a Phase 1b study of CDI-988 for norovirus prevention and treatmentMar 9, 2026
- Cocrystal Pharma receives IRB approval for Phase 1b norovirus challenge study of CDI-988Dec 18, 2025
- Cocrystal Pharma showcases CDI-988, the first oral antiviral in development for norovirus infection, in a podium presentation at the International Calicivirus ConferenceSep 12, 2025